mRNAワクチンと治療薬市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、治療タイプ別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Polaris Market Research社の最新調査によると、mRNAワクチンと治療薬の世界市場規模は2034年までに2,538億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

mRNAワクチンと治療薬市場は、特にCOVID-19の発生で急速な進化を遂げています。メッセンジャーRNA（mRNA）技術はCOVID-19ワクチン開発のアプローチとして登場し、これまでにないスピードと柔軟性を提供しました。この技術革新は、パンデミック時に迅速なワクチン製造の道を開き、インフルエンザ、がん、HIVなど幅広い疾患に対する将来のワクチンや治療薬に計り知れない可能性を秘めたものです。

従来のワクチン開発では、最適な抗原を特定し、ウイルスサンプルを増殖させ、大量のワクチンを製造するために、しばしば長いプロセスを必要としました。対照的に、mRNA技術では病原体の遺伝暗号を迅速に解読し、必要な抗原をコードするmRNAを合成することができます。つまり、mRNAワクチンは、遺伝子配列が分かれば、どのような感染症に対してもすぐに開発できるということです。この能力により、インフルエンザやジカウイルスなど、COVID-19以外の疾患に対するmRNAワクチンの研究が進められています。

mRNA治療薬は、他の用途、特に腫瘍学への応用が検討されています。Moderna社やBioNTech社など数社が、mRNAベースのがんワクチンの臨床試験を開始しており、初期には有望な結果が得られています。これらのワクチンは、単独療法として、あるいは化学療法や免疫療法などの他の治療法との併用で、さまざまながんの治療に使用される可能性があります。

mRNAワクチンと治療薬市場レポートハイライト

用途別では、個別化がんワクチンやがん免疫療法の開発を可能にすることでがん治療に革命をもたらすmRNA技術の能力により、がん分野は予測期間中に急成長が見込まれます。

タイプ別では、従来の非増幅型mRNAワクチンセグメントは、その有効性が実証され、COVID-19の発生時に広く採用されたことから、2024年のmRNAワクチンと治療薬市場シェアを独占しました。

世界市場では、強固なヘルスケアインフラ、研究開発への多額の投資、mRNA技術の急速な進歩により、北米が2024年に最大の収益シェアを占めました。

世界の主要市場企業の一例としては、Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のmRNAワクチンと治療薬市場の洞察

• 市場スナップショット
• mRNAワクチンと治療薬市場力学
  • 促進要因と機会
    • 研究開発（R&D）、コラボレーション、戦略的パートナーシップの拡大
    • mRNAベースの製品に対する規制承認の増加
  • 抑制要因と課題
    • 厳格な規制基準
• PESTEL分析
• mRNAワクチンと治療薬の市場動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界のmRNAワクチンと治療薬市場：タイプ別

• 主な調査結果
• イントロダクション
• 自己増幅型mRNAワクチン
• 従来の非増幅mRNAワクチン

第6章 世界のmRNAワクチンと治療薬市場：用途別

• 主な調査結果
• イントロダクション
• がん
• 感染症
• 自己免疫疾患
• その他

第7章 世界のmRNAワクチンと治療薬市場：治療タイプ別

• 主な調査結果
• イントロダクション
• モノクローナル抗体
• 遺伝子治療
• 細胞療法
• その他

第8章 世界のmRNAワクチンと治療薬市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 調査機関・研究機関
• 病院
• クリニック
• その他

第9章 世界のmRNAワクチンと治療薬市場：地域別

• 主な調査結果
• イントロダクション
  • mRNAワクチンと治療薬市場評価：地域、2020-2034年
• 北米
  • 北米：タイプ別、2020-2034年
  • 北米：用途別、2020-2034年
  • 北米：治療タイプ別、2020-2034年
  • 北米：エンドユーザー別、2020-2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：タイプ別、2020-2034年
  • 欧州：用途別、2020-2034年
  • 欧州：治療タイプ別、2020-2034年
  • 欧州：エンドユーザー別、2020-2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：タイプ別、2020-2034年
  • アジア太平洋地域：用途別、2020-2034年
  • アジア太平洋地域：治療タイプ別、2020-2034年
  • アジア太平洋地域：エンドユーザー別、2020-2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：タイプ別、2020-2034年
  • 中東・アフリカ：用途別、2020-2034年
  • 中東・アフリカ：治療タイプ別、2020-2034年
  • 中東・アフリカ：エンドユーザー別、2020-2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：タイプ別、2020-2034年
  • ラテンアメリカ：用途別、2020-2034年
  • ラテンアメリカ：治療タイプ別、2020-2034年
  • ラテンアメリカ：エンドユーザー別、2020-2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Pfizer Inc.
• Moderna, Inc.
• BioNTech SE
• GlaxoSmithKline
• Daiichi Sankyo
• BioNTech SE
• CureVac N.V.
• AstraZeneca
• Ethris
• Sanofi
• Arcturus Therapeutics
• Innovac Therapeutics
• Kernal Biologics
• Pantherna Therapeutics
• Ziphius Vaccines

List of Tables:

Table 1 Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 2 Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 3 Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 4 Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 5 North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 7 North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 8 North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 9 U.S.: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 11 U.S.: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 12 U.S.: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 13 Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 15 Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 16 Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 17 Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 19 Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 20 Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 21 UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 23 UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 24 UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 25 France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 26 France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 27 France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 28 France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 29 Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 31 Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 32 Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 33 Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 35 Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 36 Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 37 Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 39 Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 40 Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 41 Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 43 Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 44 Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 45 Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 47 Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 48 Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 51 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 52 Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 55 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 56 Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 57 China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 58 China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 59 China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 60 China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 61 India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 62 India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 63 India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 64 India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 65 Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 67 Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 68 Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 69 Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 71 Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 72 Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 73 Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 75 Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 76 Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 77 South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 79 South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 80 South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 81 Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 83 Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 84 Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 97 UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 99 UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 100 UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 101 Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 103 Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 104 Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 105 South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 107 South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 108 South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 113 Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 115 Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 116 Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 117 Mexico: mRNA vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: mRNA vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 119 Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 120 Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 121 Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 123 Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 124 Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 125 Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 127 Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 128 Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global mRNA Vaccines and Therapeutics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global mRNA Vaccines and Therapeutics Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global mRNA Vaccines and Therapeutics Market, by Application, 2024 & 2034 (USD Billion)

Figure 10. Market by Treatment Type

Figure 11. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2024 & 2034 (USD Billion)

Figure 12. Market by End User

Figure 13. Global mRNA Vaccines and Therapeutics Market, by End User, 2024 & 2034 (USD Billion)

The global mRNA vaccines and therapeutics market size is expected to reach USD 253.83 billion by 2034, according to a new study by Polaris Market Research. The report "mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Self-Amplifying mRNA-Based Vaccines and Conventional Non-Amplifying mRNA-Based Vaccines), Application, Treatment Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The mRNA vaccines and therapeutics market has seen a rapid evolution, particularly with the emergence of the COVID-19 outbreak. Messenger RNA (mRNA) technology emerged as an approach for COVID-19 vaccine development, offering unprecedented speed and flexibility. This innovation has created the way for rapid vaccine production during the pandemic and holds immense potential for future vaccines and therapeutics for a wide array of diseases such as influenza, cancer, and HIV.

Traditional vaccine development often requires lengthy processes to identify the most suitable antigens, grow virus samples, and produce large quantities of vaccine doses. In contrast, mRNA technology allows for rapid sequencing of a pathogen's genetic code, followed by the synthesis of mRNA that encodes the required antigen. This means that mRNA vaccines can be developed for any infectious disease as soon as its genetic sequence is known. This capability has prompted the exploration of mRNA vaccines for diseases beyond COVID-19, including influenza and Zika virus.

mRNA therapeutics are being explored for other applications, particularly in oncology. Several companies, including Moderna and BioNTech, have begun clinical trials for mRNA-based cancer vaccines, with promising early results. These vaccines may potentially be used to treat a variety of cancers, as standalone therapies or in combination with other treatments such as chemotherapy and immunotherapy.

mRNA Vaccines and Therapeutics Market Report Highlights

In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.

Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.

In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.

A few of the global key market players are Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.

Polaris Market Research has segmented the mRNA vaccines and therapeutics market report on the basis of type, application, treatment type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

• Self-Amplifying mRNA-Based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines

By Application Outlook (Revenue, USD Billion, 2020-2034)

• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Others

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

• Monoclonal Antibody
• Gene Therapy
• Cell Therapy
• Other

By End User Outlook (Revenue, USD Billion, 2020-2034)

• Research Laboratories and Organizations
• Hospitals
• Clinics
• Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Source
  • 3.2.1. Primary Source
  • 3.2.2. Secondary Source

4. Global mRNA Vaccines and Therapeutics Market Insights

• 4.1. mRNA Vaccines and Therapeutics Market - Market Snapshot
• 4.2. mRNA Vaccines and Therapeutics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Research and Development (R&D), Collaborations, and Strategic Partnerships
    • 4.2.1.2. Increased Regulatory Approvals for mRNA-based Products
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Strict regulatory norms
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. mRNA Vaccines and Therapeutics Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global mRNA Vaccines and Therapeutics Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
• 5.3. Self-amplifying mRNA-based Vaccines
  • 5.3.1. Global mRNA Vaccines and Therapeutics Market, by Self-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)
• 5.4. Conventional Non-amplifying mRNA-based Vaccines
  • 5.4.1. Global mRNA Vaccines and Therapeutics Market, by Conventional Non-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)

6. Global mRNA Vaccines and Therapeutics Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
• 6.3. Cancer
  • 6.3.1. Global mRNA Vaccines and Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 6.4. Infectious Diseases
  • 6.4.1. Global mRNA Vaccines and Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
• 6.5. Autoimmune Diseases
  • 6.5.1. Global mRNA Vaccines and Therapeutics Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
• 6.6. Others
  • 6.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global mRNA Vaccines and Therapeutics Market, by Treatment Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
• 7.3. Monoclonal Antibody
  • 7.3.1. Global mRNA Vaccines and Therapeutics Market, by Monoclonal Antibody, by Region, 2020-2034 (USD Billion)
• 7.4. Gene Therapy
  • 7.4.1. Global mRNA Vaccines and Therapeutics Market, by Gene Therapy, by Region, 2020-2034 (USD Billion)
• 7.5. Cell Therapy
  • 7.5.1. Global mRNA Vaccines and Therapeutics Market, by Cell Therapy, by Region, 2020-2034 (USD Billion)
• 7.6. Others
  • 7.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global mRNA Vaccines and Therapeutics Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 8.3. Research Laboratories and Organizations
  • 8.3.1. Global mRNA Vaccines and Therapeutics Market, by Research Laboratories and Organizations, by Region, 2020-2034 (USD Billion)
• 8.4. Hospitals
  • 8.4.1. Global mRNA Vaccines and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 8.5. Clinics
  • 8.5.1. Global mRNA Vaccines and Therapeutics Market, by Clinics, by Region, 2020-2034 (USD Billion)
• 8.6. Others
  • 8.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global mRNA Vaccines and Therapeutics Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. mRNA Vaccines and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. mRNA Vaccines and Therapeutics Market - North America
  • 9.3.1. North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.3.3. North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.3.4. North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.3.5. mRNA Vaccines and Therapeutics Market - US
    • 9.3.5.1. US: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. US: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.3. US: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.3.5.4. US: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.3.6. mRNA Vaccines and Therapeutics Market - Canada
    • 9.3.6.1. Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.4. mRNA Vaccines and Therapeutics Market - Europe
  • 9.4.1. Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.4.3. Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.4.4. Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.5. mRNA Vaccines and Therapeutics Market - UK
    • 9.4.5.1. UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.6. mRNA Vaccines and Therapeutics Market - France
    • 9.4.6.1. France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.3. France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.6.4. France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.7. mRNA Vaccines and Therapeutics Market - Germany
    • 9.4.7.1. Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.8. mRNA Vaccines and Therapeutics Market - Italy
    • 9.4.8.1. Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.9. mRNA Vaccines and Therapeutics Market - Spain
    • 9.4.9.1. Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.10. mRNA Vaccines and Therapeutics Market - Netherlands
    • 9.4.10.1. Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.11. mRNA Vaccines and Therapeutics Market - Russia
    • 9.4.11.1. Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.12. mRNA Vaccines and Therapeutics Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.5. mRNA Vaccines and Therapeutics Market - Asia Pacific
  • 9.5.1. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.5. mRNA Vaccines and Therapeutics Market - China
    • 9.5.5.1. China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.3. China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.5.4. China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.6. mRNA Vaccines and Therapeutics Market - India
    • 9.5.6.1. India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.3. India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.6.4. India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.7. mRNA Vaccines and Therapeutics Market - Malaysia
    • 9.5.7.1. Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.8. mRNA Vaccines and Therapeutics Market - Japan
    • 9.5.8.1. Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.9. mRNA Vaccines and Therapeutics Market - Indonesia
    • 9.5.9.1. Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.10. mRNA Vaccines and Therapeutics Market - South Korea
    • 9.5.10.1. South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.11. mRNA Vaccines and Therapeutics Market - Australia
    • 9.5.11.1. Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.12. mRNA Vaccines and Therapeutics Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.6. mRNA Vaccines and Therapeutics Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.5. mRNA Vaccines and Therapeutics Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.6. mRNA Vaccines and Therapeutics Market - UAE
    • 9.6.6.1. UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.7. mRNA Vaccines and Therapeutics Market - Israel
    • 9.6.7.1. Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.8. mRNA Vaccines and Therapeutics Market - South Africa
    • 9.6.8.1. South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.9. mRNA Vaccines and Therapeutics Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.7. mRNA Vaccines and Therapeutics Market - Latin America
  • 9.7.1. Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.5. mRNA Vaccines and Therapeutics Market - Mexico
    • 9.7.5.1. Mexico: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.6. mRNA Vaccines and Therapeutics Market - Brazil
    • 9.7.6.1. Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.7. mRNA Vaccines and Therapeutics Market - Argentina
    • 9.7.7.1. Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.8. mRNA Vaccines and Therapeutics Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Pfizer Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Moderna, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. BioNTech SE
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. GlaxoSmithKline
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Daiichi Sankyo
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. BioNTech SE
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. CureVac N.V.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. AstraZeneca
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Ethris
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Sanofi
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Arcturus Therapeutics
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Innovac Therapeutics
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Kernal Biologics
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Pantherna Therapeutics
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Ziphius Vaccines
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development